Compounds > dactinomycin

dactinomycin and Chromosome Deletion

dactinomycin has been researched along with Chromosome Deletion in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, KP; Erler, T; Hoschke, B; May, M1
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ1
Ashkenazi, A; Capon, DJ; Chamow, SM; Figari, IS; Goeddel, DV; Marsters, SA; Palladino, MA; Pennica, D; Smith, DH1
Bénard, J; Da Silva, J; Riou, G; Teyssier, JR1
Meriam, C; Racaniello, VR1

Other Studies

5 other study(ies) available for dactinomycin and Chromosome Deletion

ArticleYear
[Multicystic renal tumor in a patient with WAGR syndrome].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosome Deletion; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Eye Proteins; Genes, Wilms Tumor; Homeodomain Proteins; Humans; In Situ Hybridization, Fluorescence; Kidney; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Nephrectomy; Paired Box Transcription Factors; PAX6 Transcription Factor; Polycystic Kidney Diseases; Repressor Proteins; Vincristine; WAGR Syndrome; Wilms Tumor

2007
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
    Blood, 1995, Jun-01, Volume: 85, Issue:11

    Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation

1995
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Dec-01, Volume: 88, Issue:23

    Topics: Animals; Antibodies, Monoclonal; Cell Survival; Chimera; Chromosome Deletion; Cloning, Molecular; Dactinomycin; Female; Humans; Immunoglobulin G; Immunoglobulin Heavy Chains; Kinetics; L Cells; Lymphotoxin-alpha; Mice; Mice, Inbred BALB C; Mutagenesis, Site-Directed; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Restriction Mapping; Salmonella Infections, Animal; Shock, Septic; Transfection; Tumor Necrosis Factor-alpha

1991
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
    International journal of cancer, 1989, Mar-15, Volume: 43, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromosome Deletion; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phenotype; Tumor Cells, Cultured; Verapamil; Vincristine

1989
Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA.
    Virology, 1986, Volume: 155, Issue:2

    Topics: Base Sequence; Chromosome Deletion; Dactinomycin; HeLa Cells; Mutation; Nucleic Acid Conformation; Poliovirus; RNA, Viral; Temperature; Viral Proteins; Virus Replication

1986